Avid Bioservices: A Leader in Biologics Manufacturing
On October 29, 2026, Avid Bioservices, recognized as a frontrunner in mid-scale biologics manufacturing in the United States, was honored with the prestigious Business Recognition Award by the City of Tustin. This accolade, presented in the category of Industrial Manufacturing – Life Sciences, underscores Avid's pivotal role in reinforcing domestic supply chains and establishing a benchmark for flexible biologics production capacities.
The award ceremony was graced by Council Member Ryan Gallagher, who honored Kenneth Bilenberg, Avid's Group President and CEO, in the very city where Avid's journey commenced. Tustin has played an integral part in Avid’s expansion, with its local workforce driving advancements in the entire biologics spectrum, from development processes to commercial supply chain solutions. In his acceptance speech, Bilenberg expressed gratitude for the city’s recognition, remarking, "The U.S. needs more mid-scale biologics capacity, and Avid is the clear market leader. With Tustin as our base and an outstanding track record behind us, we set the standard for helping biopharmaceutical partners bring life-changing therapies to patients worldwide."
Mayor Austin Lumbard emphasized the significance of businesses like Avid in fostering economic growth within Tustin. He noted, "Our Business Recognition Luncheon celebrates world-class businesses like Avid Bioservices that invest in Tustin, create quality jobs, and contribute to our city's economic vibrancy. As Mayor, it is a privilege to represent a community that has been home to Avid for more than 30 years, and I look forward to their continued success and contributions for years to come."
Beyond its contributions to economic growth, Avid Bioservices is actively engaged in shaping the future of the biomanufacturing workforce. The company collaborates closely with local universities and regional training programs to cultivate the next generation of talent necessary for expediting the reshoring of innovation and manufacturing back to the United States. Many students from these partnerships have already begun securing full-time roles at Avid, reinforcing its position as a leader in developing the mid-scale market's essential workforce.
Avid Bioservices is not just a leader in biologics; it stands as a beacon of industry excellence in contract development and manufacturing, offering a wide range of services such as cell line development, process development, and CGMP biologics manufacturing from DNA through to IND and commercial supply. For those interested in learning more about Avid's offerings and developments, additional information can be found on their official website:
www.avidbio.com.
In conclusion, Avid's recognition by the City of Tustin not only highlights its impactful role in the life sciences sector but also celebrates the collaborative effort between local entities to ensure the sustainable advancement of biomanufacturing, a critical field that directly influences healthcare outcomes worldwide. This award serves as a reminder of the critical importance of supporting and recognizing businesses that strive to innovate and develop solutions for the challenges faced in the biopharmaceutical industry.